Molecule Structure

Scientific Name

Mitapivat

Description of the Drug

Mitapivat is a pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB16236

Brand Name(s)

Not Available

Company Owner(s)

Agios Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Pyruvate kinase isozymes R/L SINGLE PROTEIN ACTIVATOR CHEMBL1075126

Unichem Links

SureChEMBL SCHEMBL2702716
PharmGKB PA166278021
DrugBank DB16236
PubChem: Thomson Pharma 163433338
PubChem 59634741
ChemicalBook CB72736694
Guide to Pharmacology 10473
ZINC ZINC000140430983